- Home
- NWL vs CPRX Comparison
NWL vs CPRX Comparison
Compare NWL & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NWL
- CPRX
- Stock Information
- Founded
- NWL 1903
- CPRX 2002
- Country
- NWL United States
- CPRX United States
- Employees
- NWL N/A
- CPRX N/A
- Industry
- NWL Plastic Products
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- NWL Industrials
- CPRX Health Care
- Exchange
- NWL Nasdaq
- CPRX Nasdaq
- Market Cap
- NWL 2.4B
- CPRX 2.6B
- IPO Year
- NWL N/A
- CPRX 2006
- Fundamental
- Price
- NWL $6.29
- CPRX $19.79
- Analyst Decision
- NWL Buy
- CPRX Strong Buy
- Analyst Count
- NWL 8
- CPRX 5
- Target Price
- NWL $7.31
- CPRX $33.20
- AVG Volume (30 Days)
- NWL 7.2M
- CPRX 1.5M
- Earning Date
- NWL 10-24-2025
- CPRX 08-06-2025
- Dividend Yield
- NWL 4.52%
- CPRX N/A
- EPS Growth
- NWL N/A
- CPRX 183.96
- EPS
- NWL N/A
- CPRX 1.65
- Revenue
- NWL $7,397,000,000.00
- CPRX $558,499,000.00
- Revenue This Year
- NWL N/A
- CPRX $16.51
- Revenue Next Year
- NWL $1.36
- CPRX $9.58
- P/E Ratio
- NWL N/A
- CPRX $12.03
- Revenue Growth
- NWL N/A
- CPRX 28.55
- 52 Week Low
- NWL $4.22
- CPRX $19.00
- 52 Week High
- NWL $11.78
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- NWL 64.89
- CPRX 40.60
- Support Level
- NWL $5.73
- CPRX $19.83
- Resistance Level
- NWL $6.06
- CPRX $21.19
- Average True Range (ATR)
- NWL 0.26
- CPRX 0.65
- MACD
- NWL 0.07
- CPRX 0.03
- Stochastic Oscillator
- NWL 98.44
- CPRX 13.25
About NWL Newell Brands Inc.
Newell Brands Inc is an American consumer goods company with a strong portfolio of well-known brands, including Rubbermaid, Sharpie, Graco, Coleman, Rubbermaid Commercial Products, Yankee Candle, Paper Mate, FoodSaver, Dymo, EXPO, Elmer's, Oster, NUK, Spontex and Campingaz. The group is focused on delighting consumers by lighting up everyday moments. Its segments are Home and Commercial Solutions, Learning and Development, and Outdoor and Recreation. The group geographic areas are the United States, Canada, Europe, the Middle East and Africa, Asia Pacific, and Latin America.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).